Jazz Pharmaceuticals plc (JAZZ)
USD 121.74
(-0.61%)
USD 121.74
(-0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.83 Billion | 3.65 Billion | 3.09 Billion | 2.36 Billion | 2.16 Billion | 1.89 Billion |
| Cost of Revenue | 435.57 Million | 540.51 Million | 440.76 Million | 148.91 Million | 127.93 Million | 121.54 Million |
| Gross Profit | 3.39 Billion | 3.11 Billion | 2.65 Billion | 2.21 Billion | 2.03 Billion | 1.76 Billion |
| Operating Expenses | 3.25 Billion | 2.6 Billion | 2.48 Billion | 1.44 Billion | 1.39 Billion | 1.11 Billion |
| Selling, General and Administrative Expenses | 1.34 Billion | 1.41 Billion | 1.45 Billion | 854.23 Million | 736.94 Million | 683.53 Million |
| Research and Development Expenses | 849.65 Million | 590.45 Million | 505.74 Million | 335.37 Million | 299.72 Million | 226.61 Million |
| Other Expenses | 627.28 Million | 599.16 Million | 525.76 Million | 259.58 Million | 354.81 Million | 201.49 Million |
| Cost and Expenses | 3.25 Billion | 3.14 Billion | 2.92 Billion | 1.59 Billion | 1.51 Billion | 1.23 Billion |
| Operating Income | 578.58 Million | 512.26 Million | 170.27 Million | 765.46 Million | 532.37 Million | 614.83 Million |
| Interest Expense | 289.43 Million | 288.24 Million | 278.76 Million | 99.7 Million | 72.26 Million | 77.07 Million |
| Income Tax Expense | -119.91 Million | -158.64 Million | 216.11 Million | 33.51 Million | -73.15 Million | 80.16 Million |
| Earnings before Tax | 297.92 Million | -372.78 Million | -112.83 Million | 275.09 Million | 454.3 Million | 529.46 Million |
| Net Income | 414.83 Million | -214.13 Million | -328.95 Million | 238.61 Million | 523.36 Million | 447.09 Million |
| Earnings Per Share Basic | 6.95 | -3.42 | -5.51 | 4.28 | 9.22 | 7.45 |
| Earnings Per Share Diluted | 6.10 | -3.42 | -5.51 | 4.22 | 9.09 | 7.30 |
| Weighted Average Shares Outstanding | 63.29 Million | 62.53 Million | 59.69 Million | 55.71 Million | 56.74 Million | 59.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 72.06 Million | 62.53 Million | 59.69 Million | 56.51 Million | 57.55 Million | 61.22 Million |
| Gross Margin | 0.89 | 0.85 | 0.86 | 0.94 | 0.94 | 0.94 |
| EBIT Margin | 0.38 | 0.30 | 0.22 | 0.43 | 0.46 | 0.45 |
| Profit Margin | 0.11 | -0.06 | -0.11 | 0.10 | 0.24 | 0.24 |
| EBITDA | 1.44 Billion | 553.78 Million | 1.02 Billion | 649.65 Million | 1.01 Billion | 932.66 Million |
| Earnings Before Tax Margin | 0.15 | 0.14 | 0.06 | 0.32 | 0.25 | 0.33 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Billion | 901.98 Million | 3.83 Billion | 1.01 Billion | 972.14 Million | 957.31 Million |
| Cost of Revenue | 265.12 Million | 251.21 Million | 1.04 Billion | 258.79 Million | 102.15 Million | 97.53 Million |
| Gross Profit | 758.7 Million | 650.76 Million | 2.79 Billion | 753.13 Million | 869.98 Million | 859.78 Million |
| Operating Expenses | 559.25 Million | 574.55 Million | 2.13 Billion | 550.91 Million | 697.59 Million | 702.14 Million |
| Selling, General and Administrative Expenses | 338.52 Million | 351.71 Million | - | 334.3 Million | 308.31 Million | 340.84 Million |
| Research and Development Expenses | 220.73 Million | 222.84 Million | - | 216.6 Million | 234.4 Million | 209.23 Million |
| Other Expenses | -155.22 Million | 388.57 Million | 1.47 Billion | 386.16 Million | 389.28 Million | 361.3 Million |
| Cost and Expenses | 824.38 Million | 825.77 Million | 3.17 Billion | 809.71 Million | 799.74 Million | 799.68 Million |
| Operating Income | 199.44 Million | 76.2 Million | 659.28 Million | 202.22 Million | 172.39 Million | 157.63 Million |
| Interest Expense | 62.02 Million | 66.11 Million | 351.11 Million | 89.66 Million | 71.49 Million | 73.47 Million |
| Income Tax Expense | -30.65 Million | 11.66 Million | -119.91 Million | -33.08 Million | -47.17 Million | -24.32 Million |
| Earnings before Tax | 137.92 Million | -1.6 Million | 297.92 Million | 61.52 Million | 99.51 Million | 81.78 Million |
| Net Income | 168.56 Million | -14.61 Million | 414.83 Million | 94.15 Million | 146.82 Million | 104.43 Million |
| Earnings Per Share Basic | 2.68 | -0.23 | - | 1.50 | 2.33 | 1.63 |
| Earnings Per Share Diluted | 2.42 | -0.23 | - | 1.35 | 2.06 | 1.42 |
| Weighted Average Shares Outstanding | 62.88 Million | 62.53 Million | 63.29 Million | 62.57 Million | 63.11 Million | 63.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.62 Million | 62.53 Million | 72.06 Million | 69.67 Million | 71.29 Million | 73.54 Million |
| Gross Margin | 0.74 | 0.72 | 0.73 | 0.74 | 0.89 | 0.90 |
| EBIT Margin | 0.35 | 0.27 | - | 0.36 | 0.34 | 0.33 |
| Profit Margin | 0.16 | -0.02 | 0.11 | 0.09 | 0.15 | 0.11 |
| EBITDA | 362.47 Million | 239.59 Million | - | 361.42 Million | 334.95 Million | 317.21 Million |
| Earnings Before Tax Margin | 0.19 | 0.08 | 0.17 | 0.20 | 0.18 | 0.16 |
600376
CRN
3234
SUHJY
CPWHF
3647